Search Results

Showing results 1-11 of 30 for 'Clinical trials'


  • Looking-for-genes-that-drive-cancer-yardena-samuels-thumb
    Looking for the Genes that Drive Cancer

    Prof. Yardena Samuels, who comes to Weizmann from the National Human Genome Research Institute, uses DNA sequencing to identify new genetic mutations involved in melanoma. She has already made progress by identifying a mutation – found in nearly one-fifth of melanoma cases – in a gene that is already targeted by an approved drug.

    /news-media/news-releases/looking-for-the-genes-that-drive-cancer
  • 2015-05-acwis-enews-header-isolated-thumbnail
  • Targeting_Tumors_A_New_Strategy_for_Prostate_Cancer_Treatment
  • tookad1-tn
    Weizmann Institute Drug, TOOKAD® Soluble, Approved in Mexico for Prostate Cancer Therapy

    Developed by Profs. Yoram Salomon and Avigdor Scherz, the drug TOOKAD<sup>®</sup> Soluble has been approved in Mexico for use in treating prostate cancer. The therapy, which has no side effects, offers men with prostate problems a crucial new option besides surgery or watchful waiting. Late-stage clinical trials have taken place in Europe and continue in the U.S.

    /news-media/news-releases/weizmann-institute-drug-tookad-soluble-approved-in-mexico-for-prostate-cancer-therapy
  • 2016-06-acwis-enews-june-thumbnail
    Keeping Men Healthy, the Weizmann Way

    June is Men's Health Month, which aims to raise awareness of preventable problems and promote early detection and treatment of disease. The Weizmann Institute is doing its part, with a prostate cancer treatment receiving approval and investigations into other gender-related cancers; studies on fertility; and learning how women's tears impact men.

    /news-media/feature-stories/keeping-men-healthy-the-weizmann-way
  • Lighting_the_Way_for_a_New_Cancer_Treatment
  • Research on Aging at the Weizmann Institute

    As the population in many countries trends towards maturity, keeping people healthy as they age is a priority. At the Weizmann Institute, research is taking place on a number of conditions that often arise later in life, such as prostate cancer and Alzheimer's disease.

    /news-media/feature-stories/research-on-aging-at-the-weizmann-institute
  • avigdor-scherz-tn
    Teaming Up to Defeat Prostate Cancer

    Prostate cancer is the second leading cause of cancer-related deaths among American men. That's why Prof. Avigdor Scherz, collaborating with other leading cancer researchers, is developing a promising new treatment: vascular-targeted photodynamic therapy, or VTP. Now in clinical trials, VTP uses light and a unique drug to destroy prostate tumors.

    /news-media/feature-stories/teaming-up-to-defeat-prostate-cancer
  • wv24-tn
  • May-Melanoma-2012-sstock_63014575-thumb